Hylton, Donna
Harvard University · Regeneron (United States) · Massachusetts General Hospital
2 papers on CoChat
Most cited papers
- Verified
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences
Angiogenesis and VEGF in CancerMonoclonal and Polyclonal Antibodies Research
Cited by 1,691
- Verified
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. (2003) · Blood
Psoriasis: Treatment and PathogenesisAngiogenesis and VEGF in Cancer
Cited by 367
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free